Ratings
0
Nobody has rated this yet. Be the first!
Works
9
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Cutaneous melanoma
Abstract 5025: Immune expression profiling of MAPK inhibitor resistant tumors based upon mechanisms of resistance
Cutaneous melanoma in the era of molecular profiling
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
Abstract 2822: Low intestinal microbial diversity is associated with severe immune-related adverse events and lack of response to neoadjuvant combination antiPD1, anti-CTLA4 immunotherapy
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
Abstract 2650: In depth immune profiling of the response of melanoma to MAPK inhibition
Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
